Literature DB >> 35058155

Self-rated family health history knowledge among All of Us program participants.

Leland E Hull1, Pradeep Natarajan2.   

Abstract

PURPOSE: Disparities in access to genetics services are well-documented. Family health history is routinely used to determine whether patients should be screened for heritable conditions. We sought to explore variation in levels of self-rated family health history knowledge as a possible contributer to this disparity.
METHODS: We performed a cross-sectional analysis of survey data from the All of Us Research Program. We compared the characteristics of participants who reported "None," "Some", and "A lot" of family health history knowledge using multinomial logistic regression.
RESULTS: Self-rated family health history data were available for 116,799 participants. A minority of survey participants (37%) endorsed "A lot" of knowledge about their family health history (n = 43,661). Most participants (60%) endorsed "Some" family health history knowledge (n = 69,914) and 3% (n = 3224) endorsed "None." In adjusted analyses, those who indicated "Some" family health history knowledge or "None" were more likely to be assigned male sex at birth, identify as possible gender and sexual minorities, have a self-reported race other than White, have a lower household annual income (<$25,000), or report lower educational attainment (<high school graduate) than those who endorsed "A lot" of knowledge and the reference groups.
CONCLUSION: Family health history knowledge may be limited, especially among traditionally underserved populations.
Copyright © 2021 American College of Medical Genetics and Genomics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  All of Us Research Program; Cross-sectional analysis; Family health history; Healthcare disparities; Survey research

Mesh:

Year:  2022        PMID: 35058155      PMCID: PMC8995381          DOI: 10.1016/j.gim.2021.12.006

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  15 in total

1.  Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.

Authors:  Allison W Kurian; Kevin C Ward; Nadia Howlader; Dennis Deapen; Ann S Hamilton; Angela Mariotto; Daniel Miller; Lynne S Penberthy; Steven J Katz
Journal:  J Clin Oncol       Date:  2019-04-09       Impact factor: 44.544

2.  Development of the Initial Surveys for the All of Us Research Program.

Authors:  Robert M Cronin; Rebecca N Jerome; Brandy Mapes; Regina Andrade; Rebecca Johnston; Jennifer Ayala; David Schlundt; Kemberlee Bonnet; Sunil Kripalani; Kathryn Goggins; Kenneth A Wallston; Mick P Couper; Michael R Elliott; Paul Harris; Mark Begale; Fatima Munoz; Maria Lopez-Class; David Cella; David Condon; Mona AuYoung; Kathleen M Mazor; Steve Mikita; Michael Manganiello; Nicholas Borselli; Stephanie Fowler; Joni L Rutter; Joshua C Denny; Elizabeth W Karlson; Brian K Ahmedani; Christopher J O'Donnell
Journal:  Epidemiology       Date:  2019-07       Impact factor: 4.822

Review 3.  Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing.

Authors:  Megan A Allyse; David H Robinson; Matthew J Ferber; Richard R Sharp
Journal:  Mayo Clin Proc       Date:  2018-01       Impact factor: 7.616

4.  Insurance coverage does not predict outcomes of genetic testing: The search for meaning in payer decisions for germline cancer tests.

Authors:  Laura M Amendola; M Ragan Hart; Robin L Bennett; Martha Horike-Pyne; Michael Dorschner; Brian Shirts; Gail P Jarvik
Journal:  J Genet Couns       Date:  2019-07-17       Impact factor: 2.537

5.  Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.

Authors:  Efrat Gabai-Kapara; Amnon Lahad; Bella Kaufman; Eitan Friedman; Shlomo Segev; Paul Renbaum; Rachel Beeri; Moran Gal; Julia Grinshpun-Cohen; Karen Djemal; Jessica B Mandell; Ming K Lee; Uziel Beller; Raphael Catane; Mary-Claire King; Ephrat Levy-Lahad
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-05       Impact factor: 11.205

6.  Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.

Authors:  Ranjit Manchanda; Shreeya Patel; Vladimir S Gordeev; Antonis C Antoniou; Shantel Smith; Andrew Lee; John L Hopper; Robert J MacInnis; Clare Turnbull; Susan J Ramus; Simon A Gayther; Paul D P Pharoah; Usha Menon; Ian Jacobs; Rosa Legood
Journal:  J Natl Cancer Inst       Date:  2018-07-01       Impact factor: 13.506

7.  The "All of Us" Research Program.

Authors:  Joshua C Denny; Joni L Rutter; David B Goldstein; Anthony Philippakis; Jordan W Smoller; Gwynne Jenkins; Eric Dishman
Journal:  N Engl J Med       Date:  2019-08-15       Impact factor: 176.079

8.  Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Anthony R Gregg; Mahmoud Aarabi; Susan Klugman; Natalia T Leach; Michael T Bashford; Tamar Goldwaser; Emily Chen; Teresa N Sparks; Honey V Reddi; Aleksandar Rajkovic; Jeffrey S Dungan
Journal:  Genet Med       Date:  2021-07-20       Impact factor: 8.864

9.  Diversity and inclusion for the All of Us research program: A scoping review.

Authors:  Brandy M Mapes; Christopher S Foster; Sheila V Kusnoor; Marcia I Epelbaum; Mona AuYoung; Gwynne Jenkins; Maria Lopez-Class; Dara Richardson-Heron; Ahmed Elmi; Karl Surkan; Robert M Cronin; Consuelo H Wilkins; Eliseo J Pérez-Stable; Eric Dishman; Joshua C Denny; Joni L Rutter
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

10.  Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis.

Authors:  Lei Zhang; Yining Bao; Moeen Riaz; Jane Tiller; Danny Liew; Xun Zhuang; David J Amor; Aamira Huq; Lara Petelin; Mark Nelson; Paul A James; Ingrid Winship; John J McNeil; Paul Lacaze
Journal:  Genet Med       Date:  2019-02-18       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.